Key result
Fagonia arabica extract confers cardioprotection in preclinical MI models across shared clinical hub genes.
Why the study?
Single-target conventional treatments for myocardial infarction remain inadequate and have adverse effects, motivating this evaluation of the cardioprotective potential of Fagonia arabica L. against adrenaline-induced stress-related myocardial infarction.
Does oral hydroethanolic Fagonia arabica extract provide cardioprotection by reducing serum cardiac markers (CK-MB, LDH, cardiac troponin T) in a male albino rabbit model of adrenaline-induced myocardial infarction?
Does oral hydroethanolic Fagonia arabica extract provide cardioprotection by reducing serum cardiac markers (CK-MB, LDH, cardiac troponin T) in a male albino rabbit model of adrenaline-induced myocardial infarction?
Computational and preliminary in vivo rabbit data suggest that Fagonia arabica extract may have multitarget cardioprotective potential against adrenaline-induced myocardial injury.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice; leaves open human trials of Fagonia arabica for myocardial injury.
Background Myocardial infarction (MI) remains a primary cause of cardiovascular death around the world; single-target conventional treatments remain inadequate and have adverse effects. Objectives To predict the cardioprotective potential of Fagonia arabica L. (Zygophyllaceae) against adrenaline-induced stress-related MI. Design and Methods A combined computational and experimental workflow was used. Independent validation was performed through transcriptomic analysis of the prioritized hub genes using clinical Gene Expression Omnibus (GEO) datasets and in vivo data from a rabbit model of adrenaline-induced cardiac injury. Male albino rabbits were orally administered a hydroethanolic F. arabica extract at doses of 100, 200, or 300 mg/kg/day for 14 days. The animals were challenged with adrenaline at 2 mg/kg subcutaneously on the 14th and 15th days. Serum cardiac markers, including CK-MB, LDH, and cardiac troponin T, were measured on the 16th day. Results A total of 147 overlapping targets were identified, including major hub nodes such as AKT1 and TNF, and the predictions indicated favorable interactions with seven lead phytochemicals. In-depth analysis of independent clinical GEO datasets (GSE66360 and GSE48060) using transcriptomic data showed that 20 hub genes among the prioritized genes were significantly differentially expressed in patients with myocardial infarction compared with controls. A 90% concordance in gene regulation was observed across the two cohorts. There was a significant increase in CK-MB, LDH, and troponin T levels following adrenaline injection compared with the control group. Conclusion The results of this in vivo study lend preliminary support to the cardioprotective potential of F. arabica extract. Along with the computational results and independent transcriptomic validation of predicted hub genes in clinical GEO datasets, these findings support the multitarget hypothesis involving i) myocardial injury, ii) inflammatory signaling, iii) oxidative stress, and iv) cardiomyocyte survival. However, these findings must be substantiated by further investigations, including direct target engagement and histopathological evidence of protection.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied Adrenaline-induced myocardial infarction. Hydroethanolic Fagonia arabica extract vs. Control group was evaluated on Serum cardiac markers (CK-MB, LDH, and cardiac troponin T) and differential expression of prioritized hub genes. Fagonia arabica phytochemicals targeted 147 MI-related nodes, with 20 hub genes differentially expressed in clinical MI cohorts (90% concordance) and preliminary in vivo cardioprotection in rabbits.
Synapse has enriched 10 related papers. Consider them for comparative context: